Abstract
Although synthesis of adult hemoglobin (alpha 2 beta 2) is reduced or absent in both alpha and beta thalassemias, these disorders differ in their clinical significance to the fetus and neonate. alpha-Globin synthesis is observed in the yolk sac by 3 weeks of gestation and, by 9 weeks of gestation, alpha-globin represents the main alpha-like hemoglobin in the fetus. By contrast, the switch to beta-globin chain synthesis usually remains incomplete until 1 year after birth. Therefore, the clinical manifestations of homozygous beta-thalassemia may be ameliorated by sustained synthesis of fetal hemoglobin during the first 6 months of life, whereas up until 10 years ago, homozygous alpha-thalassemia was invariably associated with death in utero. More recently, reports of infants with homozygous alpha-thalassemia surviving the neonatal period have emerged, observations particularly relevant to large numbers of immigrants to North America from Southeast Asia, where alpha-thalassemia is common. Studies of patients with the beta-globin disorders thalassemia and sickle cell disease showed that the severity of both disorders is ameliorated by sustained synthesis of fetal hemoglobin into adult life. Hence, treatment for both these disorders...Continue Reading
References
Nov 1, 1978·British Journal of Haematology·M E PembreyR P Perrine
Jan 1, 1992·Acta Haematologica·T K LamC S Feng
Jul 4, 1991·The New England Journal of Medicine·O S PlattT R Kinney
Jan 1, 1985·Annals of the New York Academy of Sciences·A W NienhuisG Dover
Jan 14, 1988·The New England Journal of Medicine·C T NoguchiA N Schechter
May 1, 1986·The Journal of Pediatrics·M A BeaudryY W Kan
May 1, 1986·The Journal of Pediatrics·D W BianchiL Wolfe
Dec 2, 1972·Lancet·R P PerrineA May
Jan 1, 1967·British Journal of Haematology·D J Weatherall, P A McIntyre
Mar 1, 1970·British Journal of Haematology·D J WeatherallW H Boon
Oct 23, 1969·The New England Journal of Medicine·H A PearsonE A Cornelius
Jul 1, 1980·British Journal of Haematology·W G WoodD J Weatherall
Dec 9, 1982·The New England Journal of Medicine·T J LeyA W Nienhuis
Oct 1, 1983·The Biochemical Journal·W G Wood, D J Weatherall
Jul 26, 1984·The New England Journal of Medicine·J D McInerney
Jan 14, 1993·The New England Journal of Medicine·S P PerrineN F Olivieri
Sep 16, 1993·The New England Journal of Medicine·C H Lowrey, A W Nienhuis
May 18, 1995·The New England Journal of Medicine·S CharacheD R Bonds
May 1, 1995·Obstetrics and Gynecology·S CarrJ Dailey
Jun 15, 1995·The New England Journal of Medicine·G D SherN F Olivieri
Jun 1, 1995·British Journal of Haematology·E A RachmilewitzG Dover
Jun 9, 1994·The New England Journal of Medicine·O S PlattP P Klug
Sep 1, 1994·The New England Journal of Medicine·G M BrittenhamJ W Harris
Sep 1, 1994·The New England Journal of Medicine·N F OlivieriA R Cohen
Mar 1, 1994·Blood Reviews·A CaoM C Rosatelli
Sep 16, 1993·The New England Journal of Medicine·G LucarelliR A Clift
Jun 1, 1996·The Journal of Pediatrics·J P ScottR J Labotka
Citations
Dec 13, 2005·Annals of the New York Academy of Sciences·Sylvia T SingerElliott P Vichinsky
Jul 23, 2020·Pediatric Research·Raimund PechlanerUrsula Kiechl-Kohlendorfer
Oct 18, 2005·British Journal of Haematology·Sylvia T SingerUNKNOWN E/beta Thalassaemia Study Group
Sep 30, 2008·American Journal of Hematology·Sylvia T SingerUNKNOWN E/beta Thalassemia Study Group
Apr 17, 2019·Blood Advances·Jose A HernandezAnita M Quintana